openPR Logo
Press release

Drug Discovery Services Market Report till 2022: Medicinal Chemistry to be the Largest Type of Drug Discovery Services

03-28-2018 08:26 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

FACT.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. This particular research report titled “Drug Discovery Services Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2026” has been added to the wide online database of FACT.MR which discusses the present as well as future market scenario. Readers can access knowledge related to market volume, regional expanse as well as competitive landscape prevailing in the global “Drug Discovery Services Market”. In order to study development patterns, this smart assessment also focuses on market dynamics, which talks about drivers, restraints and opportunities estimated to influence the concerned market during the period until 2022.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=375

The report compiled by Fact.MR expects the global drug discovery services market is to witness robust growth, registering CAGR of 8.9% during 2017-2026. By the end of 2026, the global drug discovery services market is projected to reach US$ 16,800.1 million revenue. Increasing prevalence of chronic diseases and new diseases is driving the drug discovery services. Also, new technologies supporting drug discovery methods and techniques are evolving at a significant phase. Following are insight on how the global drug discovery services market will perform in the near future.

Hit-To-Lead Identification to Gain Maximum Traction

Compared to the various processes in the drug discovery services, Hit-To-Lead identification is anticipated to gain maximum traction. Hit-To-Lead identification is likely to exceed US$ 6,900 million revenue towards 2026 end. Increasing research based on the High-Throughput Screening (HTS) is the main factor driving the use of hit-to-lead identification process.

Medicinal Chemistry to be the Largest Type of Drug Discovery Services

Medicinal chemistry is projected to emerge as the largest type in the drug discovery services market. Medicinal chemistry is estimated to bring in close to US$ 6,100 million revenue. There has been an increase in the outsourcing by pharmaceutical companies, this is emerging as the driving factor. Many drug discovery services providers based in Asia are increasing their foothold in North America and Europe.

Browse Full Report with TOC- https://www.factmr.com/report/375/drug-discovery-services-market

Table of Content:

1. Global Economic Outlook

2. Global Drug Discovery Services Market - Executive Summary

3. Global Drug Discovery Services Market Overview
4. Global Drug Discovery Services Market Analysis and Forecast 2012-2026
5. North America Drug Discovery Services Market Size and Forecast, 2012-2026
6. Latin America Drug Discovery Services Market Size and Forecast, 2012-2026
7. Europe Drug Discovery Services Market Size and Forecast, 2012-2026
8. Japan Drug Discovery Services Market Size and Forecast, 2012-2026
9. APEJ Drug Discovery Services Market Size and Forecast, 2012-2026

10. MEA Drug Discovery Services Market Size and Forecast, 2012-2026

11. Global Drug Discovery Services Market Company Share, Competition Landscape and Company Profiles
12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

Continued….

Check Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=375

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Services Market Report till 2022: Medicinal Chemistry to be the Largest Type of Drug Discovery Services here

News-ID: 995219 • Views:

More Releases from Fact.MR

Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 billion by 2034
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 …
The global dry powder inhaler (DPI) market is estimated to be worth US$ 1.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% to reach a valuation of US$ 2.2 billion by the end of 2034, according to a comprehensive study conducted by Fact.MR. Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=7083 The demand for dry powder inhalers is expected to rise due to the
Global ISO Certification Market is projected to expand at a CAGR of 15.2% from 2024 to 2034
Global ISO Certification Market is projected to expand at a CAGR of 15.2% from 2 …
According to a recently released Fact.MR analysis, the global market for ISO certification is expected to be valued at US$ 16.14 billion by 2024. By the end of 2034, revenue from ISO certification is expected to grow at a 15.2% compound annual growth rate and reach a market valuation of US$ 66.25 billion. In order to prove compliance with environmental, quality, or information security rules, a variety of sectors require ISO
Gluten-free Bakery Products Market is expected to grow at a CAGR of 9.8% from 2024-2034
04-25-2024 | Food & Beverage
Fact.MR
Gluten-free Bakery Products Market is expected to grow at a CAGR of 9.8% from 20 …
The gluten-free bakery products market is a dynamic sector influenced by various factors such as consumer dietary preferences, health trends, and advancements in food technology. As awareness of celiac disease and gluten sensitivities grows, so does the demand for gluten-free alternatives in baked goods. Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3035 Gluten is a protein fraction generated from wheat, rye, barley, oats, and their derivatives and hybrids. It is an essential part
Pet Grooming Services Market is projected to expand at a CAGR of 7.2% from 2024 to 2034
Pet Grooming Services Market is projected to expand at a CAGR of 7.2% from 2024 …
The global pet grooming services market is anticipated to rise at a compound annual growth rate (CAGR) of 7.2%, from a value of US$ 3.3 billion in 2024 to US$ 6.7 billion by the end of 2034, according to the most recent market research analysis published by Fact.MR. Pets are now considered members of the family by many. Pet owners want the best for their furry pals, just as much as

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug